At 16:05 p.m. on September 23, the Forbes real-time richest list showed that Zhong Yun, founder of Nongfu Spring, had a net worth of 59.4 billion US dollars, once again becoming the richest person in China.

On September 22, Nongfu Spring was included in the Hong Kong Stock Connect. It closed up 1.94% on the same day at a price of HK$36.70. On September 23, Nongfu Spring continued its gains, closing up 7.08% to HK$39.3.

In addition to Nongfu Spring, Zhong Yun is also a major shareholder of Wantai Biotech in the A-share market. On September 23, Wantai Biotech closed up 8.3% to 201.01 yuan. According to reports, Wantai Biotech's nasal spray influenza virus vector COVID-19 vaccine is the only COVID-19 vaccine currently approved for clinical trials that uses a nasal spray vaccination method. It acts as a protective effect by activating local immune responses and systemic immune responses by simulating the natural transmission route of respiratory viruses. Early animal experimental results showed that the vaccine had good safety and immunogenicity.

Previously, on the morning of September 8, with two listed companies, Zhong Yun's net worth once reached HK$448 billion, or about 57.8 billion US dollars. According to real-time data from the Forbes list of the richest people at the time, he won the title of richest man in China. However, on the first day of Nongfu Spring's listing, the stock price declined after opening at HK$39.8 and closed at HK$33.1. After closing, Zhong Yun's net worth reached 52 billion US dollars, ranking among the top three richest people in China.